Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Controversies in Allergy: Should Severe Asthma with Eosinophilic Phenotype Always Be Treated with Anti-IL-5 Therapies.

Pavord ID., Hanania NA.

More information Original publication

DOI

10.1016/j.jaip.2019.03.010

Type

Journal article

Publication Date

2019-05-01T00:00:00+00:00

Volume

7

Pages

1430 - 1436

Total pages

6

Addresses

R, e, s, p, i, r, a, t, o, r, y, , M, e, d, i, c, i, n, e, , U, n, i, t, , a, n, d, , O, x, f, o, r, d, , R, e, s, p, i, r, a, t, o, r, y, , N, I, H, R, , B, R, C, ,, , N, u, f, f, i, e, l, d, , D, e, p, a, r, t, m, e, n, t, , o, f, , M, e, d, i, c, i, n, e, ,, , U, n, i, v, e, r, s, i, t, y, , o, f, , O, x, f, o, r, d, ,, , O, x, f, o, r, d, ,, , U, K, ., , E, l, e, c, t, r, o, n, i, c, , a, d, d, r, e, s, s, :, , i, a, n, ., p, a, v, o, r, d, @, n, d, m, ., o, x, ., a, c, ., u, k, .

Keywords

Humans, Asthma, Eosinophilia, Nitric Oxide, Immunoglobulin E, Anti-Asthmatic Agents, Interleukin-5, Vital Capacity, Peak Expiratory Flow Rate, Forced Expiratory Volume, Administration, Inhalation, Severity of Illness Index, Respiration, Middle Aged, Male, Receptors, Interleukin-5, Interleukin-4 Receptor alpha Subunit, Antibodies, Monoclonal, Humanized, Omalizumab, Clinical Decision-Making, Fluticasone-Salmeterol Drug Combination